Meeting Wed, 07/15/2020 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
New Drugs June 2020
Agenda
DUR Agenda July 2020
Criteria
DUR Criteria
Clinical and Fiscal Edits
Media
Ampyra Clinical Edit June 2020
Crysvita Clinical Edit June 2020
Diacomit Clinical Edit June 2020
Gamifant Clinical Edit June 2020
Iron Injectable Step Therapy Edit June 2020
Koselugo Clinical Edit June 2020
Luxturna Clinical Edit June 2020
Orilissa Clinical Edit June 2020
Oxervate Clinical Edit June 2020
Palynziq Clinical Edit June 2020
PTH and Bone Resorption Suppression Related Agents Clinical Edit June 2020
Reblozyl Clinical Edit June 2020
Synagis Clinical Edit June 2020
Tepezza Clinical Edit June 2020
Tolvaptan Clinical Edit June 2020
DUR Criteria
Preferred Drug List Proposed Edits
Media
Alpha Glucosidase Inhibitors PDL Edit June 2020
Amylin Analogs PDL Edit June 2020
Antibiotics Vaginal Agents PDL Edit June 2020
Antibiotics GI Oral Agents PDL Edit
Antihyperuricemic Agents PDL Edit June 2020
Anti-Migraine Agents Alternative Oral Agents PDL Edit June 2020
Biguanides & Combination Agents PDL
Bile Salt Agents PDL Edit June 2020
Bone Ossification Agents PDL Edit June 2020
BPH July 2020
CAPS Agents PDL Edit June 2020
Cephalsporins July 2020
Colony Stimulating Factors PDL Edit June 2020
DPPIV July 2020
Elect Depleters - Potassium Lowering July 2020
Elect Depleters - Phosphate Lowering July 2020
Erythropoiesis Stimulating Agents PDL Edit June 2020
Fluoroquinolones Oral PDL Edit June 2020
GH GHRF Select Agents July 2020
GH Somatropin Agents July 2020
GLP1 Receptor Agonists and Combination Agents PDL Edit June 2020
Hepatitis C Agents PDL Edit June 2020
Insulins Long Acting PDL Edit June 2020
Insulins Non-Analogs PDL Edit June 2020
Insulins Rapid Acting PDL Edit June 2020
Insulins Mixed PDL Edit June 2020
Macrolides PDL Edit June 2020
Meglitinides PDL Edit June 2020
Methotrexate Agents PDL Edit June 2020
Multiple Sclerosis Injectable Agents PDL Edit June 2020
Multiple Sclerosis Oral Agents PDL Edit June 2020
Penicillins PDL Edit June 2020
SGLT2 Inhibitors and Combination Agents PDL Edit June 2020
Sulfonylureas 2nd Generation PDL Edit June 2020
Tetracyclines PDL Edit June 2020
Thiazolidinediones and Combination Agents PDL Edit June 2020
Thrombocytopenia Agents PDL Edit June 2020
TIMS IL6 Receptor Inhibitors July 2020
TIMS IL17 July 2020
TIMS JAK Inhibitors July 2020
TIMS Select Agents July 2020
TIMS TNF Inhibitors July 2020
Urinary Tract Antispasmodics PDL Edit June 2020
Page
Drug Utilization Review Board Meeting Information